-
Signature
-
/s/ Kristen Williams, Attorney-in-Fact
-
Issuer symbol
-
PCRX
-
Transactions as of
-
31 May 2023
-
Net transactions value
-
-$12,700
-
Form type
-
4
-
Filing time
-
02 Jun 2023, 18:28:58 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
PCRX |
Common Stock |
Options Exercise |
$85,000 |
+2,500 |
+10% |
$34.00 |
26,894 |
31 May 2023 |
Direct |
F1 |
| transaction |
PCRX |
Common Stock |
Sale |
$97,700 |
-2,500 |
-9.2% |
$39.08 |
24,591 |
31 May 2023 |
Direct |
F1, F2 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
PCRX |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-2,500 |
-100% |
$0.000000* |
0 |
31 May 2023 |
Common Stock |
2,500 |
$34.00 |
Direct |
F1, F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: